Abiomed is a medical technology company founded in 1981 in Danvers, Massachusetts, originally to develop the world’s first artificial heart. The company is best known for its Impella line of catheter-based heart pumps, which provide temporary circulatory support during cardiac procedures and heart failure treatment. [1]
Design and History
Abiomed’s visual identity has undergone two significant transformations. The first was a complete brand overhaul undertaken when the company’s technology outpaced its existing brand promise and visual identity. The rebranding effort included brand identity, messaging, and a tagline, and was applied across corporate communications, advertising, trade show materials, product design, user manuals, and even FDA approval documents. The new brand focused on the lives improved by the company’s products rather than on the devices themselves. [2] [3]
The second major change came after Johnson & Johnson acquired Abiomed in 2022. In September 2024, Johnson & Johnson announced that its MedTech companies, including Abiomed, would operate under the name Johnson & Johnson MedTech as part of a renewed brand and visual identity first announced in September 2023. [4]
From January 2025, Abiomed’s brand identity visually adapted to that of Johnson & Johnson MedTech, with the company describing the transition as “same content, new design.” The Impella brand continues to represent the heart pump product category, while the Abiomed name is retained primarily for product-related services such as training platforms and software solutions. [5]
The German Brand Award recognized the brand integration work, noting that the agency Klondike developed a corporate brand design that coded the transition through a shift from blue to red, aligning Abiomed under the Johnson & Johnson master brand. [6]
Meaning and Symbolism
The pre-2025 Abiomed logo mark is documented in a U.S. trademark filing as consisting of four oval images stacked two over two, with the oval at the lower right larger than the other three. The filing notes that color is not claimed as a feature of the mark. [7] An earlier trademark registration for the ABIOMED word mark, registered in 2008, was classified under design search codes for miscellaneous circular designs with an irregular circumference and four circles. [8]
The trademark records describe only the visual composition and do not attribute meaning to the shapes.
Typography and Design
The trademark registrations describe the mark’s design elements but do not specify typography details. The current Johnson & Johnson MedTech branding, adopted from January 2025, uses the visual identity system of the parent company rather than a standalone Abiomed wordmark. [5]
Logo Index is an independent educational archive covering logos, visual identities and graphic design history. All trademarks and brand assets remain the property of their respective owners.
